Expert Approaches to Common Bleeding and Thrombotic Problems, Part II

References
1 Hayward CP, Webert KE. Expert approaches to common bleeding and thrombotic problems-part I. Semin Thromb Hemost 2012; 38 (7) 641-644
2 Rojas-Hernandez CM, Garcia DA. The novel oral anticoagulants. Semin Thromb Hemost 2013; 39 (2) 117-126
3 Tagalakis V, Wharin C, Kahn SR. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Semin Thromb Hemost 2013; 39 (2) 127-140
4 Schulman S. Optimal duration of anticoagulant therapy. Semin Thromb Hemost 2013; 39 (2) 141-146
5 Hylek EM. Anticoagulant therapy for atrial fibrillation. Semin Thromb Hemost 2013; 39 (2) 147-152
6 George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost 2013; 39 (2) 153-160
7 Balduini CL, Pecci A, Noris P. Diagnosis and management of inherited thrombocytopenia. Semin Thromb Hemost 2013; 39 (2) 161-171
8 De Simone N, Sarode R. Diagnosis and management of common acquired bleeding disorders. Semin Thromb Hemost 2013; 39 (2) 172-181
9 Shander A, Javidroozi M. The approach to patients with bleeding disorders who do not accept blood-derived products. Semin Thromb Hemost 2013; 39 (2) 182-190
10 Federici AB, Budde U, Castaman G, Rand JH, Tiede A. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost 2013; 39 (2) 191-201
11 Lippi G, Franchini M, Cervellin G. Diagnosis and management of ischemic heart disease. Semin Thromb Hemost 2013; 39 (2) 202-213
12 Targher G, Byrne CD. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. Semin Thromb Hemost 2013; 39 (2) 214-228
13 Hayward CP, Bunimov N. Thrombocytopenic platelet disorders. Semin Thromb Hemost 2011; 37 (6) 617-620
14 Kadir RA, McLintock C. Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost 2011; 37 (6) 640-652
15 Cramer Bordé E, Ouzegdouh Y, Ledgerwood EC, Morison IM. Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death. Semin Thromb Hemost 2011; 37 (6) 664-672
16 Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 2011; 37 (6) 673-681
17 Millikan PD, Balamohan SM, Raskind WH, Kacena MA. Inherited thrombocytopenia due to GATA-1 mutations. Semin Thromb Hemost 2011; 37 (6) 682-689
18 Di Paola J, Johnson J. Thrombocytopenias due to gray platelet syndrome or THC2 mutations. Semin Thromb Hemost 2011; 37 (6) 690-697
19 Nurden A, Pilllois X, Fiore M, Heilig R, Nurden P. Macrothrombocytopenias caused by mutations in the genes encoding the aIIbb3 integrin. Semin Thromb Hemost 2011; 37 (6) 698-706
20 Toriello HV. Thrombocytopenia-absent radius syndrome. Semin Thromb Hemost 2011; 37 (6) 707-712
21 Blavignac J, Bunimov N, Rivard GE, Hayward CP. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost 2011; 37 (6) 713-720
22 Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009; 35 (2) 189-203